News

Lorus Therapeutics has published data from study of its novel anti cancer therapy, conducted by its research team. In the study, data was presented from the preclinical evaluation

Impax Pharmaceuticals has reported the positive results from a recently completed phase II trial of its late-stage Parkinson’s disease drug candidate IPX066. In the cross-over trial, IPX066 reduced

PerkinElmer has announced the launch of the Columbus 2.0 platform, its high content screening (HCS) data management software for cellular imaging and analysis. The Columbus 2.0 software is

AssistMed has executed an agreement with Kerr Health Care Services, a Specialty Pharmacy Provider (SPP), to implement AssistMed’s Patient Adherence and Disease Management Solutions. Under the agreement, AssistMed

Praxair China has installed its NCOOL cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical. The company claims that it is the first liquid nitrogen supply

Forest Laboratories and Glenmark Pharmaceuticals, a subsidiary of Glenmark Pharmaceuticals India (GPL) have announced top-line results from a phase IIb dose range finding study of Oglemilast in patients

Arena Pharmaceuticals has reported positive top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial. BLOSSOM confirms the results previously reported for the

Buck Systems, part of GEA Pharma has reported that Burkert has successfully built pneumatic-control systems. The system will be used to vibrate pharmaceutical-powder mixing and delivery systems for

In addition, should the company satisfy the criteria for initial listing on The NASDAQ Capital Market (except for bid price) as of March 15, 2010, the company will